https://www.selleckchem.com/pr....oducts/meclofenamate
Background Deep brain stimulation (DBS) is a well-established treatment for a variety of movement disorders. Rechargeable cell technology was introduced to pulse generator more than 10 years ago and brought great benefits to patients. However, with the widespread use of rechargeable implanted pulse generators (r-IPGs), a new hardware complication, when charging the r-IPG has been difficult, was encountered. Objective The aims of this study were to report five cases confronted with r-IPG charging difficulty postoperatively a